EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Machine Learning-Driven Metabolomic Biomarker Discovery in Glioblastoma: Advances, Challenges, and Future Directions

Tiffany Shih, Rawad Hodeify iD, Jasprit Kaur, Mohammad Alnuaimi iD, Orwa Aboud

International Journal of Molecular Sciences · 26.04.2026 · 27 (9) · 3842

DOI: 10.3390/ijms27093842 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.04.2026. Verfasst von Tiffany Shih und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, Sacramento, CA 95817, USA. Hauptthemen laut MEDLINE: Glioblastoma, Machine Learning, Metabolomics, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is an aggressive tumor type known to recur after maximal safe surgical resection followed by concurrent radiation therapy (RT) and chemotherapy (temozolomide—TMZ), and adjuvant TMZ maintenance chemotherapy. It exhibits high intratumor heterogeneity within a single specimen, and thus clinical management remains a challenge due to its rapid progression and high recurrence rate. Machine learning algorithms are currently being implemented in biomarker discovery to develop accurate predictive models that can guide clinical decision making. Emerging evidence identifies metabolomics as a critical player in understanding tumor metabolism and progression. Machine learning computation models have been instrumental in GBM classification and biomarker discovery, as well as the evaluation of tumor staging. Metabolomic profiling of biogenic amines in the setting of surgery, chemoradiation, and understanding relapse also suggests a coordination between metabolic pathways and tumor stage. Many challenges in machine learning and metabolomics-based approaches for disease classification remain due to the dimensionality of datasets, as well as identifying more streamlined panels of metabolite biomarkers. The purpose of this review is to showcase the recent developments in the applications of machine learning in metabolomics as a promising approach to enhancing the biomarker discovery process for future classification and interpretation of patient response to therapies for GBM management in the clinical setting. It also presents the major challenges of implementing machine learning approaches in GBM management and its future directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMachine LearningMetabolomicsBiomarkers, TumorBrain NeoplasmsHumansPredictive Learning ModelsMetabolome

Stichwörter der Autor:innen

biogenic aminesglioblastomamachine learningmetabolomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurology, University of California, Sacramento, CA 95817, USA.
  • Department of Biotechnology, School of Arts and Sciences, American University of Ras Al Khaimah, Ras Al Khaimah 72603, United Arab Emirates.
  • University of California, Davis, CA 95616, USA.
  • UC Davis Comprehensive Cancer Center, University of California, Davis, Sacramento, CA 95817, USA.
  • Departments of Neurological Surgery, University of California, Davis, Sacramento, CA 95817, USA.

ORCID-Profile: Rawad Hodeify, Mohammad Alnuaimi

Förderung

  • NCI NIH HHS

Zitieren

APA

Shih, T., Hodeify, R., Kaur, J., Alnuaimi, M., & Aboud, O. (2026). Machine Learning-Driven Metabolomic Biomarker Discovery in Glioblastoma: Advances, Challenges, and Future Directions. International Journal of Molecular Sciences, 27(9), 3842. https://doi.org/10.3390/ijms27093842

Vancouver

Shih T, Hodeify R, Kaur J, Alnuaimi M, Aboud O. Machine Learning-Driven Metabolomic Biomarker Discovery in Glioblastoma: Advances, Challenges, and Future Directions. International Journal of Molecular Sciences. 2026;27(9):3842. doi:10.3390/ijms27093842

BibTeX
@article{Shih2026,
  author = {Shih, Tiffany and Hodeify, Rawad and Kaur, Jasprit and Alnuaimi, Mohammad and Aboud, Orwa},
  title = {Machine Learning-Driven Metabolomic Biomarker Discovery in Glioblastoma: Advances, Challenges, and Future Directions},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {3842},
  doi = {10.3390/ijms27093842}
}
Kostenlos starten →